Company news
Curis, Inc. (NASDAQ:CRIS) news
Curis, Inc. news releases on 6ix. Latest, May 12, 2020: Curis Reports First Quarter 2020 Financial Results
Press releases — page 3
Curis Reports First Quarter 2020 Financial Results
May 11, 2020
Curis to Release First Quarter 2020 Financial Results and Hold Conference Call on May 12, 2020
May 4, 2020
Curis Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
March 18, 2020
Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
February 26, 2020
Curis® and DarwinHealth Announce Scientific Collaboration to Characterize Biomarkers and Tumor Subtype Alignments for Fimepinostat in DLBCL and Solid Malignancies
January 12, 2020
Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies
January 6, 2020
Curis Announces Positive Safety, Tolerability and Pharmacokinetic Data in Ongoing Phase 1 Study of Fimepinostat in Combination with Venetoclax
December 5, 2019
Curis Reports Third Quarter 2019 Financial Results
November 4, 2019
Curis to Release Third Quarter Financial Results and Hold Conference Call on November 5, 2019
October 28, 2019
Curis Reports Second Quarter 2019 Financial Results
August 5, 2019
Curis to Release Second Quarter Financial Results and Hold Conference Call on August 6, 2019
July 29, 2019
Curis Reports First Quarter 2019 Financial Results
May 13, 2019
Curis Completes Mesothelioma Enrollment in CA-170 Study
May 5, 2019